Children’s cough. How to recognize the cause and what to do?

Бойкова, Н. Э.; Гаращенко, Т. И.

doi:10.21518/2079-701x-2018-17-124-127

Cited by 3 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Для этого необходимо оценить характеристики кашля: частоту, интенсивность, продолжительность, течение, продуктивность, тембр, ритм, время возникновения, характер, периодичность, болезненность, положение тела в момент кашля и др. [7,13,14].…”

Section: в помощь врачуunclassified

Cough in Children: Pediatricians’ Tactics

Козловский¹

2023

Педиатрия. Восточная Европа

View full text Add to dashboard Cite

Данная статья посвящена теме лечения кашля у детей. Представлены современные данные о причинах и механизмах развития кашля. Изложена подробная характеристика кашля. Рассмотрено этиологическое и симптоматическое лечение кашля при острых респираторных вирусных инфекциях у детей. Большое внимание уделено противовирусной терапии, в которой особое место занимает препарат инозин пранобекс (Гроприносин). Приведены данные о его клинической эффективности при лечении острых респираторных вирусных инфекций у детей. Показана эффективность монтелукаста (Синглона) при затяжном и хроническом кашле у детей. This article is devoted to cough treatment in children. Current data on cough causes and mechanisms are presented. A detailed description of cough is outlined. Etiological and symptomatic treatments of cough in acute respiratory viral infections in children are considered. Antiviral therapy, in which the drug inosine pranobex (Groprinosin) occupies a special place, is given a considerable attention. Data on its clinical efficacy in treatment of acute respiratory viral infections in children are presented. The efficacy of montelukast (Singlon) in lingering and chronic cough in children is demonstrated.

show abstract

Section: в помощь врачуunclassified

Cough in Children: Pediatricians’ Tactics

Козловский¹

2023

Педиатрия. Восточная Европа

View full text Add to dashboard Cite

show abstract

Combination therapy for cough and bronchial obstruction in childhood

2019

View full text Add to dashboard Cite

The inflammatory process in the bronchial mucosa of various origins (infectious, allergic, irritative, etc.) cause changes in the sputum production and its rheological properties, slowing of mucociliary clearance. Mucoactive therapy is one of the important components of the management of bronchopulmonary diseases. The article provides a detailed review of the modern literature, as well as the authors’ own experience regarding the cough therapy methods, including techniques used in the bronchial obstructive syndrome. The use of combination drugs, which simultaneously affect various pathogenetic mechanisms of inflammation and cough, including those in the respiratory diseases with bronchial obstructive syndrome, becomes a promising direction of mucoactive therapy. Due to relative safety and clinical efficacy, the modern combination therapy, including a fixed-dose combination of salbutamol, bromhexine, guaifenesin (Ascoril, Ascoril expectorant), is increasingly becoming the drug of informed choice in mild bronchial obstruction in childhood in pediatric practice.

show abstract

Prospects for dry cough therapy with Herbion®, Iceland moss syrup, during tripledemic: A review

Vavilova,

Vavilov

2024

Pediatr. Con. Med.

View full text Add to dashboard Cite

Cough is a common reason for seeking medical care, regardless of the season, but especially during the increased prevalence of respiratory infections and other diseases often associated with prolonged cough. Cough is an essential physiological protective reflex that cleanses the airways of secretions and inhaled or aspirated substances; however, it significantly worsens the child's condition. A dry, unproductive, persistent cough especially affects the quality of life. The article addresses various aspects of using the medicinal product Herbion®, Iceland moss syrup, for treating dry, unproductive, persistent cough in various diseases, including post-infectious cough.

show abstract

Children’s cough. How to recognize the cause and what to do?

Abstract: The article considers the variety of factors that favor the occurrence of cough and describes its types in detail. Particular attention is paid to the prevalence of dry cough; an optimal variant of pharmacotherapy with the choice of a modern centrally active antitussive drug is suggested.

Cited by 3 publications

References 24 publications

Cough in Children: Pediatricians’ Tactics

Cough in Children: Pediatricians’ Tactics

Combination therapy for cough and bronchial obstruction in childhood

Prospects for dry cough therapy with Herbion®, Iceland moss syrup, during tripledemic: A review

Contact Info

Product

Resources

About